Panagora Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Panagora Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-171	Closed	-$3K	–	2331
2021 Q2	$3K	Hold	171	–	–	﹤0.01%	2590
2021 Q1	$3K	Hold	171	–	–	﹤0.01%	2676
2020 Q4	$3K	Hold	171	–	–	﹤0.01%	2583
2020 Q3	$3K	Hold	171	–	–	﹤0.01%	2559
2020 Q2	$3K	Hold	171	–	–	﹤0.01%	2443
2020 Q1	$3K	Hold	171	–	–	﹤0.01%	2358
2019 Q4	$3K	Hold	171	–	–	﹤0.01%	2330
2019 Q3	$3K	Hold	171	–	–	﹤0.01%	2353
2019 Q2	$3K	Hold	171	–	–	﹤0.01%	2512
2019 Q1	$3K	Buy	+171	New	+$3.44K	﹤0.01%	2443

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Panagora Asset Management's TAK Position: Q3 2021 in Review

Panagora Asset Management sold out of Takeda Pharmaceutical (TAK) in Q3 2021, closing a stake of 171 shares — an estimated $3K sold.

Panagora Asset Management first reported a position in TAK in Q1 2019 and held it in 10 quarters. The position peaked at $3K in Q2 2021. 292 funds tracked by Wall St. Rank hold TAK as of Q3 2021.

Panagora Asset Management reported no remaining Takeda Pharmaceutical position as of Q3 2021 after selling out during the quarter.
Panagora Asset Management sold 171 Takeda Pharmaceutical shares in Q3 2021, an estimated $3K.
Panagora Asset Management first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 10 quarters.
Panagora Asset Management's Takeda Pharmaceutical position peaked at $3K in Q2 2021.
292 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.